Abstract
Introduction: The aim of this study was, first, to investigate the difference in fetal atrioventricular conduction in patients with and without intrahepatic cholestasis of pregnancy (ICP) by measuring the fetal PR interval; second, to evaluate the altering effect of ursodeoxycholic acid (UDCA) treatment on the fetal PR interval in ICP patients. Methods: The study consisted of 42 ICP patients and 48 healthy pregnant women. Fetal echocardiography was performed to measure the mechanical PR interval. The fetal PR interval and the clinical characteristics were compared between the two groups. The effect of UDCA treatment on the fetal PR interval in ICP patients was evaluated. Results: In ICP patients, significantly longer fetal PR intervals were observed than in the control group (123.21 ± 8.54 vs. 115.13 ± 5.95 ms, p < 0.001). In the ICP group, there was a positive correlation between the fetal PR interval and maternal fasting total bile acid (TBA) levels (r = 0.514, p = 0.001). After 1 week of treatment with UDCA in patients with ICP, the PR interval was shorter than before, although the reduction was not statistically significant (120.98 ± 6.70 vs. 123.21 ± 8.54 ms, p = 0.095). In patients with severe ICP (TBA >40 mmol/L, n = 10), a significant reduction in the fetal PR interval was observed after treatment with UDCA (127.5 ms [IQR, 118.0–134.75] before vs. 122 ms [IQR, 109.5–126.5] after, p = 0.037). Conclusion: Fetal PR interval increased in ICP patients in correlation with maternal serum TBA concentration. Treatment with UDCA may have limited positive effects on the fetal AV conduction system. The beneficial effects of UDCA on the fetal PR interval may be more pronounced in patients with higher bile acid levels.
Journal Section:
Clinical Fetal Medicine
References
1.
Geenes
V
, Williamson
C
. Intrahepatic cholestasis of pregnancy
. World J Gastroenterol
. 2009
;15
(17
):2049
–66
. 2.
Ovadia
C
, Seed
PT
, Sklavounos
A
, Geenes
V
, Di Ilio
C
, Chambers
J
, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses
. Lancet
. 2019
;393
(10174
):899
–909
. 3.
Alsulyman
OM
, Ouzounian
JG
, Ames-Castro
M
, Goodwin
TM
. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management
. Am J Obstet Gynecol
. 1996
;175
(4 Pt 1
):957
–60
. 4.
Gorelik
J
, Harding
SE
, Shevchuk
AI
, Koralage
D
, Lab
M
, de Swiet
M
, et al. Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics
. Clin Sci
. 2002
;103
(2
):191
–200
. 5.
Sepulveda
W
, Gonzalez
C
, Cruz
M
, Rudolph
M
. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins
. Eur J Obstet Gynecol Reprod Biol
. 1991
;42
(3
):211
–5
. 6.
Williamson
C
, Miragoli
M
, Kadir
SSA
, Abu-Hayyeh
S
, Papacleovoulou
G
, Geenes
V
, et al. Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy
. Dig Dis
. 2011
;29
(1
):58
–61
. 7.
Pasquini
L
, Seale
AN
, Belmar
C
, Oseku-Afful
S
, Thomas
MJ
, Taylor
MJ
, et al. PR interval: a comparison of electrical and mechanical methods in the fetus
. Early Hum Dev
. 2007
;83
(4
):231
–7
. 8.
Bergman
G
, Wahren‐Herlenius
M
, Sonesson
SE
. Diagnostic precision of Doppler flow echocardiography in fetuses at risk for atrioventricular block
. Ultrasound Obstet Gynecol
. 2010
;36
(5
):561
–6
. 9.
Bicocca
MJ
, Sperling
JD
, Chauhan
SP
. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines
. Eur J Obstet Gynecol Reprod Biol
. 2018
;231
:180
–7
. 10.
Bacq
Y
, le Besco
M
, Lecuyer
A-I
, Gendrot
C
, Potin
J
, Andres
CR
, et al. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: results in real-world conditions and factors predictive of response to treatment
. Dig Liver Dis
. 2017
;49
(1
):63
–9
. 11.
Manzotti
C
, Casazza
G
, Stimac
T
, Nikolova
D
, Gluud
C
. Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy
. Cochrane Database Syst Rev
. 2019
;7
(7
). 12.
Chappell
LC
, Bell
JL
, Smith
A
, Linsell
L
, Juszczak
E
, Dixon
PH
, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial
. Lancet
. 2019
;394
(10201
):849
–60
. 13.
Adeyemi
O
, Alvarez-Laviada
A
, Schultz
F
, Ibrahim
E
, Trauner
M
, Williamson
C
, et al. Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis
. PLoS One
. 2017
;12
(9
):e0183167
. 14.
Vasavan
T
, Deepak
S
, Jayawardane
IA
, Lucchini
M
, Martin
C
, Geenes
V
, et al. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations
. J Hepatol
. 2021
;74
(5
):1087
–96
. 15.
Di Mascio
D
, Quist-Nelson
J
, Riegel
M
, George
B
, Saccone
G
, Brun
R
, et al. Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review
. J Matern Fetal Neonatal Med
. 2021
;34
(21
):3614
–22
. 16.
Kenyon
AP
, Piercy
CN
, Girling
J
, Williamson
C
, Tribe
R
, Shennan
A
. Obstetric cholestasis, outcome with active management: a series of 70 cases
. BJOG An Int J Obstet Gynaecol
. 2002
;109
(3
):282
–8
. 17.
Glickstein
JS
, Buyon
J
, Friedman
D
. Pulsed Doppler echocardiographic assessment of the fetal PR interval
. Am J Cardiol
. 2000
;86
(2
):236
–9
. 18.
Rodriguez
M
, Bombin
M
, Ahumada
H
, Bachmann
M
, Sepúlveda-Martínez
A
, Sepúlveda‐Martínez
A
. Fetal cardiac dysfunction in pregnancies affected by intrahepatic cholestasis of pregnancy: a cohort study
. J Obstet Gynaecol Res
. 2022
;48
(7
):1658
–67
. 19.
Guerra
M
, Montaño
I
, Haye
MT
, Toro
V
, Maiz
N
. Fetal PR interval in pregnancies with intrahepatic cholestasis of pregnancy: a case–control study
. Am J Perinatol
. 2024
;41
(S 01
):e2964
–9
. 20.
Henry
A
, Welsh
A
. Monitoring intrahepatic cholestasis of pregnancy using the fetal myocardial performance index: a cohort study
. Ultrasound Obstet Gynecol
. 2015
;46
(5
):571
–8
. 21.
Ozel
A
, Alici Davutoglu
E
, Eric Ozdemir
M
, Oztunc
F
, Madazli
R
. Assessment of fetal left ventricular modified myocardial performance index and its prognostic significance for adverse perinatal outcome in intrahepatic cholestasis of pregnancy
. J Matern Fetal Neonatal Med
. 2020
;33
(12
):2000
–5
. 22.
Williamson
C
, Gorelik
J
, Eaton
BM
, Lab
M
, Swiet
M
, Korchev
Y
. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis
. Clin Sci
. 2001
;100
(4
):363
–9
. 23.
Strehlow
SL
, Pathak
B
, Goodwin
TM
, Perez
BM
, Ebrahimi
M
, Lee
RH
. The mechanical PR interval in fetuses of women with intrahepatic cholestasis of pregnancy
. Am J Obstet Gynecol
. 2010
;203
(5
):455. e1
–4555
. 24.
Rodríguez
M
, Moreno
J
, Márquez
R
, Eltit
R
, Martinez
F
, Sepúlveda-Martínez
A
, et al. Increased PR interval in fetuses of patients with intrahepatic cholestasis of pregnancy
. Fetal Diagn Ther
. 2016
;40
(4
):298
–302
. 25.
Yakut
K
, Öcal
FD
, Öztürk
M
, Öztürk
FH
, Oğuz
Y
, Çelen
Ş
. Assessment of mechanical fetal PR interval in intrahepatic cholestasis of pregnancy and its relationship with the severity of the disease
. Am J Perinatol
. 2020
;37
(14
):1476
–81
. 26.
Walker
KF
, Chappell
LC
, Hague
WM
, Middleton
P
, Thornton
JG
. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy
. Cochrane Database Syst Rev
. 2020
;7
(7
). 27.
Gorelik
J
, Shevchuk
A
, Diakonov
I
, De Swiet
M
, Lab
M
, Korchev
Y
. Dexamethasone and ursodeoxycholic acid protect against the arrhythmogenic effect of taurocholate in an in vitro study of rat cardiomyocytes
. BJOG An Int J Obstet Gynaecol
. 2003
;110
(5
):467
–74
. 28.
Miragoli
M
, Kadir
SHSA
, Sheppard
MN
, Salvarani
N
, Virta
M
, Wells
S
, et al. A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart
. Hepatology
. 2011
;54
(4
):1282
–92
. 29.
Rodríguez
M
, Sprohnle
A
, Muñoz
J
, Cadena
C
, Corvalán
R
, Sepúlveda‐Martínez
A
. Treatment of intrahepatic cholestasis of pregnancy with ursodeoxycholic acid associated with improvement of fetal first‐degree atrioventricular block
. Ultrasound Obstet Gynecol
. 2018
;52
(6
):801
–2
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
